The central government has given its consent on rolling out a Human Papillomavirus (HPV) vaccination campaign targeting girls in the 9-14 age group. Dr Shweta Wazir, Consultant – Obstetrics and Gynecology, Motherhood Hospital, Gurugram said that, “I strongly support the upcoming cervical cancer immunization campaign in India. This move is not only dealing with a vital health issue but also signifies the Indian government’s commitment towards women’s wellbeing. According to a study published in the medical journal The Lancet, out of the 40 per cent of deaths that occurred due to cervical cancer globally, 23 per cent were from India, and 17 per cent were from China. Moreover, one in four deaths caused by cervical cancer also occurs in India. The global evidence for HPV vaccination as an intervention against cervical cancer is strong on whether it works or not. There are many studies conducted both within and outside India, which show that vaccines work.
The inclusion of boys in the vaccination drive is a commendable step, acknowledging the role they play in transmitting the Human Papillomavirus (HPV). By vaccinating both genders, we not only protect women but also contribute to reducing the overall prevalence of HPV-related diseases.
It not only targets cervical cancer but also provides a shield against related malignancies and genital warts. Therefore, this integrative safeguarding strategy can go a long way in reducing these negative health outcomes that are associated with HPV infections leading to malignancy.”